Operating Grant: Alternative Radiopharmaceuticals for Medical Imaging – Funding Decisions Notification (September 2009 Competition: 200909MIS)
The Canadian Institutes of Health Research (CIHR) is pleased to announce the results of the Operating Grant: Alternative Radiopharmaceuticals for Medical Imaging competition.Funding Opportunity Summary
The objective of the funding opportunity "Operating Grant: Alternative Radiopharmaceuticals for Medical Imaging" was to provide funds to accelerate the development of clinically useful alternatives to the 99mTc radiopharmaceuticals that are currently produced using molybdenum generators derived from nuclear reactors. This objective includes alternative sources of Technetium production and alternative radionuclide labels for clinical radiopharmaceuticals. Projects that that can bring a new radiopharmaceutical to the clinic within a few months are strongly encouraged. At the same time, it is recognized that other alternatives exist that will need more time and significant funding to become clinically useful, hence the overall two year granting period of this RFA. Both types of application are invited in response to this RFA.
Funding Competition Summary
A total of 19 applications were received of which 7 were approved for funding.
Contact Information
For further information about this competition, please contact:
Mary Fraser Valiquette
Team Lead
Canadian Institutes of Health Research
Telephone: 613-941-4394
Fax: 613-954-1800
Email: mary.fraservaliquette@cihr-irsc.gc.ca
For further information about this initiative and the objectives of this funding opportunity please contact:
Judith Bray
Assistant Director
CIHR Institute of Cancer Research
Telephone: 613-954-7223
Fax: 613-954-1800
Email: judith.bray@cihr-irsc.gc.ca
Funding Decisions Data Report
Access the "Alternative Radiopharmaceuticals for Medical Imaging" funding decisions data report.